Resultados globales: 6 registros encontrados en 0.02 segundos.
Artículos, Encontrados 6 registros
Artículos Encontrados 6 registros  
1.
12 p, 682.4 KB Peripheral Inflammatory Indexes Neutrophil/Lymphocyte Ratio (NLR) and Red Cell Distribution Width (RDW) as Prognostic Biomarkers in Advanced Solitary Fibrous Tumour (SFT) Treated with Pazopanib / Hidalgo-Ríos, Samuel (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Carrillo García, Jaime (Hospital Universitario General de Villalba. Servicio de Oncología Médica) ; Moura, David S. (Hospital Universitario General de Villalba. Servicio de Oncología Médica) ; Stacchiotti, Silvia (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia)) ; López Pousa, Antonio (Institut d'Investigació Biomèdica Sant Pau) ; Redondo, Andrés (Hospital Universitario La Paz. Servicio de Oncología Médica. Instituto de Investigación en Salud (IdiPAZ)) ; Italiano, Antoine (Institut Bergonié. Department of Oncology) ; Gutiérrez, Antonio (Hospital Universitari Son Espases (Palma de Mallorca, Balears)) ; Grignani, Giovanni (Candiolo Cancer Institute. FPO - IRCCS) ; Hindi, Nadia (Hospital Universitario Fundación Jiménez Díaz. Servicio de Oncología Médica) ; López-Guerrero, J.A (Laboratory of Molecular Biology. Fundación Instituto Valenciano de Oncología) ; Garcia del Muro, Xavier (Institut d'Investigació Biomèdica de Bellvitge) ; Martínez-Trufero, Javier (Hospital Universitario Miguel Servet. Servicio de Oncología Médica) ; Palmerini, Emanuela (IRCCS Istituto Ortopedico Rizzoli (Bologna)) ; Sebio, Ana (Institut d'Investigació Biomèdica Sant Pau) ; Bernabeu, Daniel (Hospital Universitario La Paz. Sección de Radiología musculoesquelética) ; Le Cesne, Axel (Gustave Roussy Cancer Campus. Department of Medical Oncology) ; Casali, Paolo Giovanni (Fondazione IRCCS Istituto Nazionale dei Tumori. Adult Mesenchymal and Rare Tumor Unit. Department of Cancer Medicine) ; Blay, Jean-Yves (Department of Medical Oncology. Centre Léon Bérard. Université Claude Bernard Lyon) ; Cruz-Jurado, Josefina (Hospital Universitario de Canarias. Servicio de Oncología Médica) ; Martín-Broto, Javier (Hospital Universitario Fundación Jiménez Díaz. Servicio de Oncología Médica)
Pazopanib was assessed prospectively in the GEIS-32 phase II study (NCT02066285) on advanced solitary fibrous tumour (SFT), resulting in a longer progression-free survival (PFS) and overall survival (OS) compared with historical controls treated with chemotherapy. [...]
2022 - 10.3390/cancers14174186
Cancers, Vol. 14 Núm. 17 (september 2022) , p. 4186  
2.
10 p, 1.2 MB SELNET clinical practice guidelines for soft tissue sarcoma and GIST / Blay, Jean-Yves (Léon Bérard Center (Lyon)) ; Hindi, Nadia (Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz) ; Bollard, Julien (Léon Bérard Center (Lyon)) ; Aguiar Júnior, Samuel (A.C.Camargo Cancer Center (Brasil)) ; Ángel, Martín Osvaldo (Instituto Alexander Fleming (Buenos Aires)) ; Araya, Beatriz (Hospital Dr. R. A. Calderón Guardia (San José)) ; Badilla-González, Ronald (Hospital Dr. Rafael Ángel Calderón Guardia (San José)) ; Bernabeu, Daniel (Hospital Universitario La Paz (Madrid)) ; Campos, Fernando (A.C.Camargo Cancer Center (Brasil)) ; Caro-Sánchez, C.H.S. (Instituto Nacional de Cancerología (Tlalpan)) ; Carvajal, B. (Fundación GIST México (Mexico)) ; Carvajal Montoya, A. (Hospital Dr. Rafael Ángel Calderón Guardia (San José)) ; Casavilca-Zambrano, Sandro (Instituto Nacional de Enfermedades Neoplásicas (Lima)) ; Castro-Oliden, Victor (Instituto Nacional de Enfermedades Neoplásicas (Lima)) ; Chacón, Matias (Instituto Alexander Fleming (Buenos Aires)) ; Clara, Miguel (Instituto Nacional de Cancerología (Tlaplan)) ; Collini, Paola (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà)) ; Correa Genoroso, Raquel (Hospital Universitario Virgen de la Victoria (Màlaga, Andalusia)) ; Costa, Felipe D. (A.C.Camargo Cancer Center (Brasil)) ; Cuellar, M. (Fundación GIST México (Mexico)) ; Dei Tos, Angelo (Treviso General Hospital Treviso (Padua)) ; Dominguez Malagón, Hugo Ricardo (Instituto Nacional de Cancerología (Tlalpan)) ; Donati, Davide Maria (IRCCS Istituto Ortopedico Rizzoli (Bologna)) ; Dufresne, Armelle (Léon Bérard Center (Lyon)) ; Eriksson, Mikael (Skane University Hospital (Lund)) ; Farias-Loza, M. (Instituto Nacional de Enfermedades Neoplásicas (Lima)) ; Fernandez, Piga (Fundación GIST (Xile)) ; Frezza, Anna Maria (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà)) ; Frisoni, Tommaso (IRCCS Istituto Ortopedico Rizzoli (Bologna)) ; Garcia-Ortega, Dorian Yarih (Instituto Nacional de Cancerología (Tlalpan)) ; Gelderblom, Hans J (Leiden University Medical Center (Leiden)) ; Gouin, François (Léon Bérard Center (Lyon)) ; Gómez-Mateo, María Carmen (Hospital Universitario Miguel Servet (Saragossa)) ; Gronchi, Alessandro (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà)) ; Haro-Varas, Juan (Instituto Nacional de Enfermedades Neoplásicas (Lima)) ; Huanca, Lourdes (Instituto Nacional de Enfermedades Neoplásicas (Lima)) ; Jimenez, Natalia (Hospital Dr. Rafael Ángel Calderón Guardia (San José)) ; Karanian, Marie (Léon Bérard Center (Lyon)) ; Kasper, Bernd (University of Heidelberg (Mannheim)) ; Lopes David, B.B. (Fondazione IRCCS Istituto Nazionale dei Tumori) ; López Pousa, Antonio (Institut d'Investigació Biomèdica Sant Pau) ; Lutter, Guido (Instituto Alexander Fleming (Buenos Aires)) ; Martinez-Said, Héctor (Hospital Medica Sur (Mexico)) ; Martinez-Tlahuel, Jorge Luis (Instituto Nacional de Cancerología (Tlalpan)) ; Mello, Celso A. (A.C.Camargo Cancer Center (Brasil)) ; Morales Pérez, José Manuel (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Moura, David S. (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Nascimento, Antônio Geraldo (A.C.Camargo Cancer Center (Brasil)) ; Ortiz-Cruz, Eduardo J. (Hospital Universitario La Paz (Madrid)) ; Palmerini, Emanuela (IRCCS Istituto Ortopedico Rizzoli (Bologna)) ; Patel, Shreyaskumar (University of Texas MD Anderson Cancer Center (Houston)) ; Pfluger, Yanina (Instituto Alexander Fleming (Buenos Aires)) ; Provenzano, Salvatore (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà)) ; Righi, Alberto (IRCCS Istituto Ortopedico Rizzoli (Bologna)) ; Rodriguez, Andrés (Instituto Alexander Fleming (Buenos Aires)) ; Salas, Rodrigo (Fundación GIST México (Mexico)) ; Santos, Telma G. (A.C.Camargo Cancer Center (Brasil)) ; Scotlandi, Katia (IRCCS Istituto Ortopedico Rizzoli (Bologna)) ; Soulé, Tomás (Instituto Alexander Fleming (Buenos Aires)) ; Stacchiotti, Silvia (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà)) ; Valverde, Claudía María (Hospital Universitari Vall d'Hebron) ; Waisberg, Federico Daniel (Instituto Alexander Fleming (Buenos Aires)) ; Zamora Estrada, Esteban (Hospital Dr. Rafael Ángel Calderón Guardia (San José)) ; Martín-Broto, Javier (Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz)
2022 - 10.1016/j.ctrv.2021.102312
Cancer Treatment Reviews, Vol. 102 (january 2022) , p. 102312  
3.
10 p, 1.4 MB SELNET clinical practice guidelines for bone sarcoma / Blay, Jean-Yves (Léon Bérard Center (Lyon)) ; Palmerini, Emanuela (IRCCS Istituto Ortopedico Rizzoli (Bologna)) ; Bollard, Julien (Léon Bérard Center) ; Aguiar Júnior, Samuel (A.C.Camargo Cancer Center) ; Ángel, Martín Osvaldo (Instituto Alexander Fleming (Buenos Aires)) ; Araya, Beatriz (Hospital Dr. R. A. Calderón Guardia (San José)) ; Badilla-González, Ronald (Hospital Dr. R. A. Calderón Guardia (San José)) ; Bernabeu, Daniel (Hospital Universitario La Paz (Madrid)) ; Campos, Fernando (A.C.Camargo Cancer Center (Brasil)) ; CHS, Caro Sánchez (Instituto Nacional de Cancerologia (Tlalpan)) ; Carvajal Montoya, A. (Hospital Dr. R. A. Calderón Guardia (San José)) ; Casavilca-Zambrano, Sandro (Instituto Nacional de Enfermedades Neoplásicas (Lima)) ; Castro-Oliden, Victor (Instituto Nacional de Enfermedades Neoplásicas (Lima)) ; Chacón, Matias (Instituto Alexander Fleming (Buenos Aires)) ; Clara-Altamirano, Miguel Ángel (Instituto Nacional de Cancerologia (Tlalpan)) ; Collini, Paola (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà)) ; Correa Genoroso, Raquel (Hospital Universitario Virgen de la Victoria (Màlaga, Andalusia)) ; Costa, Felipe D. (A.C.Camargo Cancer Center (Brasil)) ; Cuellar, M. (Instituto Nacional de Cancerologia (Tlalpan)) ; Dei Tos, Angelo (Treviso General Hospital Treviso (Padua)) ; Domínguez Malagón, Hugo Ricardo (Instituto Nacional de Cancerología (Tlalpan)) ; Donati, Davide Maria (IRCCS Istituto Ortopedico Rizzoli (Bologna)) ; Dufresne, Armelle (Léon Bérard Center (Lyon)) ; Eriksson, Mikael (Skane University Hospital (Lund)) ; Farias-Loza, M. (Instituto Nacional de Enfermedades Neoplásicas (Lima)) ; Frezza, Anna Maria (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà)) ; Frisoni, Tommaso (IRCCS Istituto Ortopedico Rizzoli (Bologna)) ; Garcia-Ortega, Dorian Yarih (Instituto Nacional de Cancerología (Tlalpan)) ; Gelderblom, Hans J (Leiden University Medical Center (Leiden)) ; Gouin, François (Léon Bérard Center (Lyon)) ; Gómez-Mateo, María Carmen (Hospital Universitario Miguel Servet (Saragossa)) ; Gronchi, Alessandro (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà)) ; Haro-Varas, Juan (Instituto Nacional de Enfermedades Neoplásicas (Lima)) ; Hindi, Nadia (Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz) ; Huanca, Lourdes (Instituto Nacional de Enfermedades Neoplásicas (Lima)) ; Jimenez, Natalia (Hospital San Vicente de Paúl (Heredia)) ; Karanian, Marie (Léon Bérard Center (Lyon)) ; Kasper, Bernd (University of Heidelberg (Mannheim)) ; Lopes, Artur (A.C.Camargo Cancer Center (Brasil)) ; Lopes David, B.B. (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà)) ; López Pousa, Antonio (Institut d'Investigació Biomèdica Sant Pau) ; Lutter, Guido (Instituto Alexander Fleming (Buenos Aires)) ; Maki, Robert G. (University of Pennsylvania (New York)) ; Martinez-Said, Héctor (Hospital Medica Sur (Mexico)) ; Martinez-Tlahuel, Jorge Luis (Instituto Nacional de Cancerología (Tlalpan)) ; Mello, Celso A. (A.C.Camargo Cancer Center (Brasil)) ; Morales Pérez, José Manuel (Hospital Medica Sur (Mexico)) ; Moura, David S. (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Nakagawa, Suely Akiko (A.C.Camargo Cancer Center (Brasil)) ; Nascimento, Antônio Geraldo (A.C.Camargo Cancer Center (Brasil)) ; Ortiz-Cruz, Eduardo J. (Hospital Universitario La Paz (Madrid)) ; Patel, Shreyaskumar (University of Texas MD Anderson Cancer Center (Houston)) ; Pfluger, Yanina (Instituto Alexander Fleming (Buenos Aires)) ; Provenzano, Salvatore (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà)) ; Righi, Alberto (IRCCS Istituto Ortopedico Rizzoli (Bologna)) ; Rodriguez, Andrés (Instituto Alexander Fleming (Buenos Aires)) ; Santos, Telma G. (A.C.Camargo Cancer Center (Brasil)) ; Scotlandi, Katia (IRCCS Istituto Ortopedico Rizzoli (Bologna)) ; MLG, Silva (A.C.Camargo Cancer Center (Brasil)) ; Soulé, Tomás (Instituto Alexander Fleming (Buenos Aires)) ; Stacchiotti, Silvia (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà)) ; Valverde, Claudia María (Hospital Universitari Vall d'Hebron) ; Waisberg, Federico Daniel (Instituto Alexander Fleming (Buenos Aires)) ; Zamora Estrada, Esteban (Hospital Dr. R. A. Calderón Guardia (San José)) ; Martín-Broto, Javier (Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz)
Bone sarcoma are infrequent diseases, representing < 0. 2% of all adult neoplasms. A multidisciplinary management within reference centers for sarcoma, with discussion of the diagnostic and therapeutic strategies within an expert multidisciplinary tumour board, is essential for these patients, given its heterogeneity and low frequency. [...]
2022 - 10.1016/j.critrevonc.2022.103685
Critical Reviews in Oncology/Hematology, Vol. 174 (june 2022) , p. 103685  
4.
11 p, 900.3 KB Pexidartinib Long-Term Hepatic Safety Profile in Patients with Tenosynovial Giant Cell Tumors / Lewis, James H. (MedStar Georgetown University Hospital) ; Gelderblom, Hans J (Leiden University Medical Center) ; van de Sande, Michiel (Leiden University Medical Center (Països Baixos)) ; Stacchiotti, Silvia (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia)) ; Healey, John H. (Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College (Nova York, Estats Units d'Amèrica)) ; Tap, William D. (Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College (Nova York, Estats Units d'Amèrica)) ; Wagner, Andrew J. (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica)) ; López Pousa, Antonio (Institut d'Investigació Biomèdica Sant Pau) ; Druta, Mihaela (Moffitt Cancer Center (Tampa, Florida)) ; Lin, ChiaChi Chi Josh (National Taiwan University Hospital (Taipei, Taiwan)) ; Baba, Hideo Andreas (University Hospital Essen (Alemanya)) ; Choi, Youngsook (Daiichi Sankyo. Inc (Nova Jersey, Estats Units)) ; Wang, Qiang (Daiichi Sankyo. Inc (Estats Units)) ; Shuster, Dale E. (Daiichi Sankyo. Inc (Estats Units))) ; Bauer, Sebastian (University of Duisburg-Essen (Alemanya))
Background: Pexidartinib is approved in the U. S. for tenosynovial giant cell tumors (TGCTs). Herein, we assessed the hepatic safety profile of pexidartinib across patients with TGCTs receiving pexidartinib. [...]
2021 - 10.1002/onco.13629
The Oncologist, Vol. 26 Núm. 5 (may 2021) , p. e863-e873  
5.
14 p, 2.6 MB Epithelioid hemangioendothelioma, an ultra-rare cancer : a consensus paper from the community of experts / Stacchiotti, Silvia (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia)) ; Miah, Aisha B. (The Royal Marsden Hospital) ; Frezza, Anna Maria (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia)) ; Messiou, Christina (Department of Radiology. The Royal Marsden Hospital and The Institute of Cancer Research) ; Morosi, Carlo (Radiology Department. Fondazione IRCCS Istituto Nazionale Tumori) ; Caraceni, Augusto (Fondazione IRCCS Istituto Nazionale Tumori) ; Antonescu, Cristina R. (Memorial Sloan Kettering Cancer Center) ; Bajpai, Jyoti (Homi Bhabha National Institute. Medical Oncology Department) ; Baldini, Elizabeth Healey (Dana-Farber Cancer Center/Brigham) ; Bauer, Sebastian (University of Duisburg-Essen) ; Biagini, Roberto (Regina Elena National Cancer Institute) ; Bielack, Stefan S. (Klinikum Stuttgart - Olgahospital) ; Blay, Jean-Yves (Department of Medical Oncology. Centre Leon Berard. Université Claude Bernard Lyon. Unicancer) ; Bonvalot, Sylvie (Institut Curie. Department of Surgical Oncology) ; Boukovinas, Ioannis P. (Nordix) ; Bovee, Judith V.M.G. (Leiden University Medical Center) ; Boye, Kjetil (The Norwegian Radium Hospital) ; Brodowicz, Thomas (Medical University Vienna) ; Callegaro, Dario (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia)) ; De Álava, Enrique (Department of Normal and Pathological Cytology and Histology. School of Medicine. University of Seville) ; Deoras-Sutliff, M. (The EHE Foundation) ; Dufresne, Armelle (Department of Medical Oncology. Centre Leon Berard. Université Claude Bernard Lyon. Unicancer) ; Eriksson, Mikael (Department of Oncology. Skane University Hospital and Lund University) ; Errani, Costantino (Orthopaedic Service. Musculoskeletal Oncology Department. IRCCS Istituto Ortopedico Rizzoli) ; Fedenko, Alexander (Medical Oncology Division. P.A. Herzen Cancer Research Institute) ; Ferraresi, Virginia (Sarcomas and Rare Tumors Unit. IRCCS Regina Elena National Cancer Institute) ; Ferrari, Andrea (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia)) ; Fletcher, Christopher D.M. (Department of Pathology Brigham & Women's Hospital) ; Garcia del Muro, Xavier (Universitat de Barcelona) ; Gelderblom, Hans J. (Department of Medical Oncology. Leiden University Medical Center) ; Gladdy, Rebecca A. (University of Toronto and Lunenfeld-Tanenbaum Research Institute) ; Gouin, François (Department of Surgery. Centre Leon Berard) ; Grignani, Giovanni (Candiolo Cancer Institute. FPO - IRCCS) ; Gutkovich, J. (NUY Langone Medical Center) ; Haas, Rick (Department of Radiotherapy. the Leiden University Medical Center) ; Hindi, Nadia (Universidad de Sevilla. Instituto de Biomedicina de Sevilla) ; Hohenberger, Peter (Mannheim University Medical Center) ; Huang, Paul (Division of Molecular Pathology. The Institute of Cancer Research) ; Joensuu, Heikki T. (Department of Oncology. Helsinki University Hospital & Helsinki University) ; Jones, Robin Lewis (Department of Cancer. The Royal Marsden Hospital and The Institute of Cancer Research) ; Jungels, Christiane (Institut Jules Bordet. Université Libre de Bruxelles) ; Kasper, Bernd (University of Heidelberg. Mannheim University Medical Center. Sarcoma Unit) ; Kawai, Akira (Musculoskeletal Oncology and Rehabilitation Medicine. Rare Cancer Center National Cancer Center Hospital) ; Le Cesne, Axel (International Department. Gustave Roussy) ; Le Grange, Franél (UCLH - University College London Hospitals NHS Foundation Trust) ; Leithner, Andeas (Department of Orthopaedics and Trauma Medical University Graz) ; Leonard, H. (Chair of Trustees of the EHE Rare Cancer Charity (UK). Charity number 1162472) ; López Pousa, Antonio (Institut d'Investigació Biomèdica Sant Pau) ; Martin Broto, Javier (Hospital Universitario Fundación Jiménez Díaz) ; Merimsky, Ofer (Unit of Soft Tissue and Bone Oncology. Division of Oncology. Tel-Aviv Medical Center affiliated with Sackler School of Medicine. Tel Aviv University) ; Merriam, Priscilla (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica). Department of Medical Oncology) ; Miceli, Rosalba (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia)) ; Mir, Olivier (Sarcoma Group. Gustave Roussy) ; Molinari, Massimo (University of Pittsburgh Medical Center. Thomas Starzl Transplant Institute) ; Montemurro, Michael (Oncology. CHUV Lausanne) ; Oldani, Graziano (Division of Abdominal Surgery. University Hospitals of Geneva) ; Palmerini, Emanuela (Chemotherapy Unit. IRCCS Istituto Ortopedico Rizzoli) ; Pantaleo, Maria Abbondanza. (Division of Oncology. IRCCS Azienda Ospedaliero-Universitaria di Bologna) ; Patel, Sapna Pradyuman (Sarcoma Center. The University of Texas M.D. Anderson Cancer Center) ; Piperno-Neumann, Sophie (Department of Medical Oncology. Institut Curie) ; Raut, Chandrajit Premanand (Dana Farber Cancer Center. Harvard Medical School) ; Ravi, Vinod (Sarcoma Center. The University of Texas M.D. Anderson Cancer Center) ; Razak, Albiruni Ryan Abdul (Princess Margaret Cancer Centre and Sinai Healthcare System & Faculty of Medicine. University of Toronto) ; Reichardt, Peter (Helios Klinikum Berlin-Buch. Department of Oncology and Palliative Care) ; Rubin, Brian P. (Robert J. Tomsich Pathology and Laboratory Medicine Institute. Cleveland Clinic) ; Rutkowski, Piotr (Maria Sklodowska-Curie National Research Institute of Oncology. Department of Soft Tissue/Bone Sarcoma and Melanoma) ; Safwat, Akmal Ahmed (Aarhus University Hospital (Aarhus, Dinamarca)) ; Sangalli, Claudia (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia)) ; Sapisochin, Gonzalo (Multi-Organ Transplant and HPB Surgical Oncology. Division of General Surgery. Department of Surgery. University of Toronto) ; Sbaraglia, Marta (Department of Pathology. Azienda Ospedaliera Università Padova) ; Scheipl, Susanne (Department of Orthopaedics and Trauma. Medical University of Graz) ; Schöffski, Patrick (Leuven Cancer Institute) ; Strauss, Dirk Cornelius (Department of Surgery. The Royal Marsden Hospital and The Institute of Cancer Research) ; Strauss, Sandra J. (University College London Hospital) ; Sundby Hall, Kirsten (Department of Oncology. Oslo University Hospital. The Norwegian Radium Hospital) ; Tap, William D. (Department of Medicine. Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College) ; Trama, Annalisa (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia)) ; Tweddle, A. (Palliative Care. The Royal Marsden Hospital and The Institute of Cancer Research London) ; van der Graaf, Winette T.A. (The Netherlands Cancer Institute (Amsterdam, Països Baixos)) ; van de Sande, Michiel (Department of Orthopedic Surgery Bone and Soft Tissue Tumor Unit. Leiden University Medical Center) ; Van Houdt, Winan (Sarcoma and Melanoma Unit. The Netherlands Cancer Institute) ; van Oortmerssen, Gerard (Co-Chair of Sarcoma Patients EuroNet (SPAEN). Woelfersheim. Germany & Chairman of the Dutch organisation for sarcoma patients (Patiëntenplatform Sarcomen). Guest researcher at Leiden University (Leiden Institute for Advanced Computer Science). Leiden University) ; Wagner, Andrew J. (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica). Department of Medical Oncology) ; Wartenberg, Markus (Chair of the Board of Directors of Sarcoma Patients EuroNet (SPAEN). Sarcoma Patients EuroNet (SPAEN)) ; Wood, J. (The Royal Marsden NHS Foundation Trust) ; Zaffaroni, Nadia (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia)) ; Zimmermann, Camilla (Department of Supportive Care. Princess Margaret Cancer Centre and Division of Palliative Medicine. Department of Medicine. University of Toronto) ; Casali, Paolo Giovanni (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia)) ; Dei Tos, Angelo (Department of Pathology. Azienda Ospedaliera Università Padova) ; Gronchi, Alessandro (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia))
Epithelioid hemangioendothelioma (EHE) is an ultra-rare, translocated, vascular sarcoma. EHE clinical behavior is variable, ranging from that of a low-grade malignancy to that of a high-grade sarcoma and it is marked by a high propensity for systemic involvement. [...]
2021 - 10.1016/j.esmoop.2021.100170
ESMO open, Vol. 6 Núm. 3 (june 2021) , p. 100170  
6.
12 p, 577.5 KB Sarcoma European and Latin American Network (SELNET) Recommendations on Prioritization in Sarcoma Care During the COVID-19 Pandemic / Martín-Broto, Javier (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Hindi, Nadia (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Aguiar Júnior, Samuel (A.C. Camargo Cancer Center. Department of Pelvic Surgery) ; Badilla-González, Ronald (Rafael Ángel Calderón Guardia Hospital. Department of medical oncology) ; Castro-Oliden, Victor (Instituto Nacional de Enfermedades Neoplásicas (Lima, Perú)) ; Chacón, Matias (Alexander Fleming Cancer Institute (Buenos Aires, Argentina)) ; Correa Genoroso, Raquel (Hospital Universitario Virgen de la Victoria (Màlaga, Andalusia)) ; De Álava, Enrique (Universidad de Sevilla) ; Donati, Davide María (Rizzoli Orthopedic Institute) ; Eriksson, Mikael (Skåne University Hospital (Suècia)) ; Falla-Jimenez, Martin (Instituto Nacional de Enfermedades Neoplásicas (Lima, Perú)) ; German, Gisela (Hospital Oncológico Provincial (Córdoba, Argentina)) ; Gobo Silva, Maria Leticia (A.C. Camargo Cancer Center) ; Gouin, François (Centre León Bérard) ; Gronchi, Alessandro (University of Milan) ; Haro-Varas, Juan (Instituto Nacional de Enfermedades Neoplásicas (Lima, Perú)) ; Jiménez-Brenes, Natalia (San Vicente de Paúl Hospital) ; Lopes de Mello, Celso Abdon (A.C. Camargo Cancer Center) ; Kasper, Bernd (Mannheim University Medical Cente) ; Maki, Robert (University of Pennsylvania) ; Martínez-Delgado, Paula (Instituto de Biomedicina de Sevilla) ; Martínez-Said, Hector (Instituto Nacional de Cancerología (Ciutat de Mèxic)) ; Martinez-Tlahuel, Jorge Luis (Instituto Nacional de Cancerología (Mèxic)) ; Morales-Pérez, Jose Manuel (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Muñoz-Casares, Francisco Cristobal (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Nakagawa, Suely A. (A.C. Camargo Cancer Center) ; Ortiz-Cruz, Eduardo Jose (Hospital Universitario La Paz (Madrid)) ; Palmerini, Emanuela (Rizzoli Orthopedic Institute) ; Patel, Shreyaskumar (University of Texas MD Anderson Cancer Center (Houston)) ; Moura, David S. (Insituto de Biomedicina de Sevilla) ; Stacchiotti, Silvia (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia)) ; Sunyach, Marie Pierre (Centre León Bérard) ; Valverde, Claudia M. (Hospital Universitari Vall d'Hebron) ; Waisberg, Federico (Alexander Fleming Cancer Institute (Buenos Aires, Argentina)) ; Blay, Jean-Yves (Centre León Bérard) ; Universitat Autònoma de Barcelona
Background: The COVID-19 outbreak has resulted in collision between patients infected with SARS-CoV-2 and those with cancer on different fronts. Patients with cancer have been impacted by deferral, modification, and even cessation of therapy. [...]
2020 - 10.1634/theoncologist.2020-0516
The Oncologist, Vol. 25 Núm. 10 (october 2020) , p. e1562-e1573  

Vea también: autores con nombres similares
6 Stacchiotti, S.
¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.